Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy
Launched by ZHEJIANG UNIVERSITY · Aug 3, 2025
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to predict when food or liquid stays in the stomach longer than it should before a sedated gastroscopy, which is a procedure where a doctor looks inside the upper digestive system using a small camera. When stomach contents don’t empty properly, it can make the procedure harder to perform and increase the risk of serious problems like reflux or choking while the patient is sedated. The goal of this study is to create an easy way for doctors to measure and understand how much stomach content remains and what factors, like age, health conditions, or medications, might affect this.
Adults aged 18 and older who are scheduled for an elective (planned) sedated gastroscopy or sedated combined gastro-colonoscopy may be eligible to join, as long as they don’t have active bleeding in their upper digestive tract, are not pregnant or breastfeeding, and meet other safety requirements. If you participate, you’ll have your medical history reviewed and undergo the planned procedure as usual, with extra attention to measuring stomach contents. This research will help doctors better prepare and manage patients undergoing these procedures to improve safety and outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18 years.
- • Patients scheduled for elective sedated gastroscopy or sedated gastro-colonoscopy.
- • Participant provides informed consent.
- Exclusion Criteria:
- • Acute upper gastrointestinal bleeding (active hematemesis, melena, or confirmed UGIB within 24h).
- • Emergency endoscopic procedures
- • Known pregnancy or lactation
- • Subjects deemed ineligible by investigators
About Zhejiang University
Zhejiang University is a prestigious research institution located in Hangzhou, China, renowned for its commitment to advancing medical science and healthcare innovation. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university plays a pivotal role in the development and execution of clinical trials aimed at improving patient outcomes and enhancing therapeutic approaches. Leveraging its extensive resources and expertise, Zhejiang University is dedicated to fostering advancements in medical knowledge while ensuring the highest standards of ethical conduct and scientific rigor in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Hangzhou, Zhejiang, China
Yiwu, Zhejiang, China
Patients applied
Trial Officials
Diansan Su, Dr
Study Chair
Zhejiang University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported